Cybin (HELP) Interest Expenses (2021 - 2026)
Cybin (HELP) posted quarterly Interest Expenses of $68.2 million for Q1 2026, up 59.77% year-on-year from $42.7 million in Q1 2025, and up 2437.81% on a QoQ basis from -$2.9 million in Q2 2025.
Cybin (HELP) Interest Expenses (2021 - 2026) Analysis & Trends
Cybin (HELP) has reported Interest Expenses for 4 consecutive years, with $68.2 million the latest figure, recorded in Q1 2026.
- Quarterly Interest Expenses rose 59.77% year-over-year to $68.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $68.2 million (up 59.77% YoY) and the FY2026 annual result came in at $68.2 million, up 60.08% from the prior year.
- Interest Expenses advanced to $68.2 million in Q1 2026 per HELP's latest filing, from -$2.9 million in the prior quarter.
- Over the last five years, Interest Expenses for HELP reached as high as $68.2 million in Q1 2026 and fell as low as -$2.9 million in Q2 2025.
- A 3-year average of $36.4 million and a median of $40.2 million in 2025 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2025 — Interest Expenses climbed 13.42% — and 2026, when it soared 59.77%.
- Year by year, Interest Expenses stood at $37.6 million in 2024, then plunged by 107.75% to -$2.9 million in 2025, then soared by 2437.81% to $68.2 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $68.2 million, -$2.9 million, and $42.7 million for Q1 2026, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | 68.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.19 Mn |
| Mar 31, 2026 | 68.19 Mn |
| Jun 30, 2025 | -2.92 Mn |
| Jun 30, 2025 | -2.92 Mn |
| Mar 31, 2025 | 42.68 Mn |
| Mar 31, 2025 | 42.68 Mn |
| Mar 31, 2024 | 37.63 Mn |
| Mar 31, 2024 | 37.63 Mn |
| Mar 31, 2021 | 5.39 Mn |
| Mar 31, 2021 | 5.39 Mn |